3 studies found for:    BAN2401
Show Display Options
Rank Status Study
1 Recruiting A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg /kg;   Drug: BAN2401 5 mg /kg;   Drug: BAN2401 10 mg /kg;   Drug: Placebo
2 Recruiting A Study to Evaluate Safety, Tolerability, and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: BAN2401 2.5 mg/kg;   Drug: BAN2401 5.0 mg/kg;   Drug: BAN2401 10 mg/kg
3 Completed A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study
Condition: Alzheimer's Disease
Interventions: Drug: Active Comparator: A;   Drug: Placebo Comparator B;   Drug: Active Comparator B;   Drug: Placebo Comparator A

Indicates status has not been verified in more than two years